GLAXOSMITH Appoints Mr. Andries Van Rooijen and Mr. Adediran Aderemi as Directors


Wednesday, March 16, 2016 02:15PM / NSE  

Please be informed that at the meeting of the Board of Directors of GlaxoSmithKline Consumer Nigeria Plc held on 9th March 2016, the Board:

1.       Accepted resignation letters from Mr. Justin Korte and Mr. Jonathon Murray with effect from 15th February 2016 and 21st February 2016 respectively. 

2.      Appointed Mr. Andries Van Rooijen and Mr. Adediran Aderemin as non-executive Director and Executive Director of the Company respectively, effective 10th March 2016. 

Mr. Andries Van Rooijen, South African, is currently the Area Finance Director, GlaxoSmithKline Consumer Healthcare Africa. He brings a wealth of experience of over 20 years in Finance and Supply Chain from different companies, sector and geography. He was formerly on the Board of the Company from February, 2012 to December, 2013. 

Mr. Adediran Aderemin joined the Company in June 2014 as the Head of the Human Resources for GlaxoSmithKline West Africa. He was over 18 years’ experience in Human Resources, Consulting and Training. He started his career with the Lagos Chamber of Commerce and Industry (LCCI) in 1997. 

He later joined British American Tobacco (BAT) in as Employee Relations Manager and held senior roles in and outside Nigeria.

Related News

1.GLAXOSMITH declares N965.04 million PAT; Proposes 30k per share dividend in 2015 Audited Result

2.GLAXOSMITH Receives an Offer from Suntory Beverage Food Ltd to Divest 

3.GLAXOSMITH declares N485.94 million PAT in Q3 15 result SP N38.20k   

4.GLAXOSMITH Running Cost and FX Loss Limits Profit Analyst Maintains HOLD Rating

5.GLAXOSMITH declares N297.3 million PAT in Q2 15 result SP N42.00k  

6.FSDH Places HOLD Rating on GLAXOSMITH Records Improvement in Revenue

Related News